Back

The impact of a chronic obstructive pulmonary disease diagnosis on the identification of heart failure

31 August 2025 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Heart failure and multi-organ impact: treatment approaches Comorbidities ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mrs Oksana Obertynska

National Pirogov Memorial Medical University, Vinnitsa (Ukraine)

7 More presentations in this session

Presentation thumbnail
Liver fibrosis and poor outcome in patients with heart failure: new insights from the BIOSTAT-CHF study
Doctor M. Win (Dundee, GB)
Abstract Slides Video
Presentation thumbnail
Cognitive impairment in malnourished heart failure patients
Mr H. Zilic (Malmo, SE)
Abstract Slides Video
Presentation thumbnail
Characteristics and prognostic significance of nutritional status in frail patients with chronic heart failure
Doctor A. Chopanova (Ashgabat, TM)
Abstract Slides Video
Presentation thumbnail
Mode of death in patients with heart failure: how trends of cardiovascular mortality and death due to cancer changed in the last 25 years.
Doctor L. Sanasi (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Prevalence of diagnosed heart failure versus other cardiovascular conditions in people with newly diagnosed type 2 diabetes mellitus: a systematic review and meta-analysis of 1.3 million individuals
Mr U. Razzaq (Glasgow, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure and multi-organ impact: treatment approaches

The Event

Event poster

ESC Congress 2025

31 August 2025 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Phenotyping of patients with chronic obstructive pulmonary disease and heart failure: data from the swedish heart failure registry
thumbnail
Congress Presentation
Towards early detection of chronic obstructive pulmonary disease across the lifespan for preventing heart failure
thumbnail
Congress Presentation
Correlation between chronic obstructive pulmonary disease and heart failure with reduced ejection fraction: is it just a comorbidity?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources